• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ebstein畸形或三尖瓣发育异常的产前早期诊断后进行性病理生理学评估。

Assessment of Progressive Pathophysiology After Early Prenatal Diagnosis of the Ebstein Anomaly or Tricuspid Valve Dysplasia.

作者信息

Selamet Tierney Elif Seda, McElhinney Doff B, Freud Lindsay R, Tworetzky Wayne, Cuneo Bettina F, Escobar-Diaz Maria C, Ikemba Catherine, Kalish Brian T, Komarlu Rukmini, Levasseur Stéphanie M, Puchalski Michael D, Satou Gary M, Silverman Norman H, Moon-Grady Anita J

机构信息

Division of Cardiology, Department of Pediatrics, Stanford University, Palo Alto, California.

Division of Cardiology, Department of Pediatrics, Stanford University, Palo Alto, California.

出版信息

Am J Cardiol. 2017 Jan 1;119(1):106-111. doi: 10.1016/j.amjcard.2016.09.022. Epub 2016 Sep 29.

DOI:10.1016/j.amjcard.2016.09.022
PMID:27793395
Abstract

In fetuses with Ebstein anomaly or tricuspid valve dysplasia (EA/TVD), poor hemodynamic status is associated with worse neonatal outcome. It is not known whether EA/TVD fetuses with more favorable physiology earlier in gestation progress to more severe disease in the third trimester. We evaluated if echocardiographic indexes in EA/TVD fetuses presenting <24 weeks of gestation are reliable indicators of physiologic status later in pregnancy. This multicenter, retrospective study included 51 fetuses presenting at <24 weeks of gestation with EA/TVD and serial fetal echocardiograms ≥4 weeks apart. We designated the following as markers of poor outcome: absence of anterograde flow across the pulmonary valve, pulmonary valve regurgitation, cardiothoracic area ratio >0.48, left ventricular (LV) dysfunction, or tricuspid valve (TV) annulus Z-score >5.6. Median gestational age at diagnosis was 21 weeks (range, 18 to 24). Eighteen fetuses (35%) had no markers for poor hemodynamic status initially, whereas only 7 of these continued to have no markers of poor outcome in the third trimester. Nine of 27 fetuses (33%) with anterograde pulmonary blood flow on the first echocardiogram developed pulmonary atresia; 7 of 39 (18%) developed new pulmonary valve regurgitation. LV dysfunction was present in 2 (4%) patients at <24 weeks but in 14 (37%) later (p <0.001). The TV annulus Z-score and cardiothoracic area both increased from diagnosis to follow-up. In conclusion, progressive hemodynamic compromise was common in this cohort. Our study highlights that care must be taken in counseling before 24 weeks, as the absence of factors associated with poor outcome early in pregnancy may be falsely reassuring.

摘要

在患有埃布斯坦畸形或三尖瓣发育异常(EA/TVD)的胎儿中,血流动力学状态不佳与新生儿预后较差相关。目前尚不清楚在妊娠早期生理状态更有利的EA/TVD胎儿在妊娠晚期是否会发展为更严重的疾病。我们评估了妊娠<24周的EA/TVD胎儿的超声心动图指标是否是妊娠后期生理状态的可靠指标。这项多中心回顾性研究纳入了51例妊娠<24周的EA/TVD胎儿,并进行了间隔≥4周的系列胎儿超声心动图检查。我们将以下情况指定为预后不良的标志物:肺动脉瓣无顺行血流、肺动脉瓣反流、心胸面积比>0.48、左心室(LV)功能障碍或三尖瓣(TV)瓣环Z评分>5.6。诊断时的中位孕周为21周(范围18至24周)。18例胎儿(35%)最初没有血流动力学状态不佳的标志物,而其中只有7例在妊娠晚期继续没有预后不良的标志物。首次超声心动图检查显示有顺行肺血流的27例胎儿中有9例(33%)发生了肺动脉闭锁;39例中有7例(18%)出现了新的肺动脉瓣反流。2例(4%)患者在<24周时出现LV功能障碍,但后来有14例(37%)出现(p<0.001)。从诊断到随访,TV瓣环Z评分和心胸面积均增加。总之,该队列中血流动力学逐渐受损很常见。我们的研究强调,在24周前进行咨询时必须谨慎,因为妊娠早期缺乏与预后不良相关的因素可能会给出错误的安慰信息。

相似文献

1
Assessment of Progressive Pathophysiology After Early Prenatal Diagnosis of the Ebstein Anomaly or Tricuspid Valve Dysplasia.Ebstein畸形或三尖瓣发育异常的产前早期诊断后进行性病理生理学评估。
Am J Cardiol. 2017 Jan 1;119(1):106-111. doi: 10.1016/j.amjcard.2016.09.022. Epub 2016 Sep 29.
2
Fetal echocardiographic prediction score for perinatal mortality in tricuspid valve dysplasia and Ebstein's anomaly.三尖瓣发育不良和 Ebstein 畸形的围产儿死亡的胎儿超声心动图预测评分。
Ultrasound Obstet Gynecol. 2020 Feb;55(2):226-232. doi: 10.1002/uog.20302.
3
Effect of In Utero Non-Steroidal Anti-Inflammatory Drug Therapy for Severe Ebstein Anomaly or Tricuspid Valve Dysplasia (NSAID Therapy for Fetal Ebstein anomaly).宫内非甾体类抗炎药治疗重度埃布斯坦畸形或三尖瓣发育不良(胎儿埃布斯坦畸形的 NSAID 治疗)。
Am J Cardiol. 2021 Feb 15;141:106-112. doi: 10.1016/j.amjcard.2020.11.013. Epub 2020 Nov 18.
4
Left ventricular function and geometry in fetuses with severe tricuspid regurgitation.严重三尖瓣反流胎儿的左心室功能和形态。
Ultrasound Obstet Gynecol. 2012 Jul;40(1):55-61. doi: 10.1002/uog.10115. Epub 2012 Jun 15.
5
Quantitative Assessment of Left Ventricular Dysfunction in Fetal Ebstein's Anomaly and Tricuspid Valve Dysplasia.胎儿埃布斯坦畸形和三尖瓣发育不良左心功能障碍的定量评估。
J Am Soc Echocardiogr. 2019 Dec;32(12):1598-1607. doi: 10.1016/j.echo.2019.07.008. Epub 2019 Sep 21.
6
Outcomes and Predictors of Perinatal Mortality in Fetuses With Ebstein Anomaly or Tricuspid Valve Dysplasia in the Current Era: A Multicenter Study.当代埃布斯坦畸形或三尖瓣发育异常胎儿围产期死亡率的结局及预测因素:一项多中心研究
Circulation. 2015 Aug 11;132(6):481-9. doi: 10.1161/CIRCULATIONAHA.115.015839. Epub 2015 Jun 9.
7
Contemporary Outcomes and Factors Associated With Mortality After a Fetal or Neonatal Diagnosis of Ebstein Anomaly and Tricuspid Valve Disease.胎儿或新生儿诊断为埃布斯坦畸形和三尖瓣疾病后的当代结局和与死亡率相关的因素。
Can J Cardiol. 2016 Dec;32(12):1500-1506. doi: 10.1016/j.cjca.2016.03.008. Epub 2016 Mar 22.
8
Perinatal outcomes following early prenatal diagnosis: insights from a single-center experience with Ebstein anomaly and tricuspid valve dysplasia.产前早期诊断后围生期结局:单中心埃布斯坦畸形和三尖瓣发育不良的经验见解。
Arch Gynecol Obstet. 2024 Sep;310(3):1491-1497. doi: 10.1007/s00404-024-07509-y. Epub 2024 Apr 29.
9
Ebstein's anomaly and tricuspid valve dysplasia: prognosis after diagnosis in utero.埃布斯坦畸形与三尖瓣发育异常:宫内诊断后的预后
Pediatr Cardiol. 2012 Dec;33(8):1391-6. doi: 10.1007/s00246-012-0355-z. Epub 2012 May 26.
10
Left ventricular myocardial performance in the fetus with severe tricuspid valve disease and tricuspid insufficiency.患有严重三尖瓣疾病和三尖瓣关闭不全胎儿的左心室心肌功能
Am J Perinatol. 2005 Feb;22(2):91-7. doi: 10.1055/s-2005-837739.

引用本文的文献

1
Ultrasound Screening in the First and Second Trimester of Pregnancy for the Detection of Fetal Cardiac Anomalies in a Low-Risk Population.孕早期和孕中期超声筛查低风险人群胎儿心脏异常情况
Diagnostics (Basel). 2025 Mar 19;15(6):769. doi: 10.3390/diagnostics15060769.
2
Management of Ebstein Anomaly in the Current Era: The Story of One Fetus and the Collaboration of Many-A Case Report.当代埃布斯坦畸形的管理:一个胎儿的故事及多方协作——病例报告
J Cardiovasc Dev Dis. 2024 May 9;11(5):147. doi: 10.3390/jcdd11050147.
3
Perinatal outcomes following early prenatal diagnosis: insights from a single-center experience with Ebstein anomaly and tricuspid valve dysplasia.
产前早期诊断后围生期结局:单中心埃布斯坦畸形和三尖瓣发育不良的经验见解。
Arch Gynecol Obstet. 2024 Sep;310(3):1491-1497. doi: 10.1007/s00404-024-07509-y. Epub 2024 Apr 29.
4
Utility of Fetal Echocardiography with Acute Maternal Hyperoxygenation Testing in Assessment of Complex Congenital Heart Defects.胎儿超声心动图联合急性母体高氧试验在复杂先天性心脏病评估中的应用价值
Children (Basel). 2023 Jan 31;10(2):281. doi: 10.3390/children10020281.
5
Risk Factors for Mortality and Circulatory Outcome Among Neonates Prenatally Diagnosed With Ebstein Anomaly or Tricuspid Valve Dysplasia: A Multicenter Study.产前诊断为埃布斯坦畸形或三尖瓣发育不良的新生儿的死亡率和循环结局的危险因素:一项多中心研究。
J Am Heart Assoc. 2020 Nov 3;9(21):e016684. doi: 10.1161/JAHA.120.016684. Epub 2020 Oct 20.
6
Prenatally diagnosed case of tricuspid valve dysplasia: A case report with review of the literature.产前诊断的三尖瓣发育异常病例:一例病例报告并文献复习
Indian J Radiol Imaging. 2019 Oct-Dec;29(4):452-456. doi: 10.4103/ijri.IJRI_463_18. Epub 2019 Dec 31.